ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Domo Launches Global COVID-19 Vaccination Tracker

New free resource introduced to keep public up to date on worldwide COVID-19 recovery efforts

Domo (Nasdaq: DOMO) today announced the launch of the Domo COVID-19 Vaccination Tracker to make domestic and international vaccination data easily accessible, understandable and actionable for all. Domo’s Vaccination Tracker has been added to the company’s free interactive Coronavirus Global Tracker, which has had more than 3 million page views to date. The Coronavirus Tracker has also been used by nearly 800 Domo customers in combination with their own business data to understand how to operate in this dynamically changing environment.

Domo’s COVID-19 Vaccination Tracker offers worldwide insights on the number of fully vaccinated individuals per the Centers for Disease Control (CDC) and Our World In Data, a scientific online publication that focuses on large global problems such as poverty, disease, hunger, climate change, war, existential risks, and inequality. The Vaccination Tracker, which is now live, shares the number of people globally that are vaccinated, and will evolve in the coming weeks to offer predictions on herd immunity and the pace at which immunizations must continue in the U.S., for example, to achieve it.

“As the world starts to see light at the end of the tunnel from this global pandemic, our team looked at additional ways to leverage data for public good. Today’s update meant finding sources that would help others quickly understand how worldwide vaccination data can impact their communities and the rapidly changing environment. We hope that the addition of the COVID-19 Vaccination Tracker will help inform organizations through the critical decisions and actions needed to get us closer to the end of this tunnel,” said Ben Schein, vice president of data curiosity at Domo.

This new addition to Domo’s Coronavirus Global Tracker speaks to the agility of Domo’s modern BI platform in rapidly adapting to new data sources and providing actionable insights. People can interact with the data that is relevant to them, and organizations can input or embed the tool as a whole to better understand and respond to the rapidly changing environment.

To explore Domo’s new Vaccinations and Testing page on the Coronavirus Global Tracker, visit here.

About Domo

Domo is the Business Cloud, empowering organizations of all sizes with BI leverage at cloud scale, in record time. With Domo, BI-critical processes that took weeks, months or more can now be done on-the-fly, in minutes or seconds, at unbelievable scale. For more information about how Domo (Nasdaq: DOMO) helps its customers go fast, go big and go bold, visit www.domo.com. You can also follow Domo on Twitter, Facebook and LinkedIn.

Domo and Domo is the Business Cloud are registered trademarks of Domo, Inc.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.